Unique ID issued by UMIN | UMIN000001043 |
---|---|
Receipt number | R000001250 |
Scientific Title | Prediction of lithium carbonate response in treatment-resistant depression using brain imaging |
Date of disclosure of the study information | 2008/03/01 |
Last modified on | 2011/03/29 16:03:06 |
Prediction of lithium carbonate response in treatment-resistant depression using brain imaging
Prediction of lithium augmentation in treatment-resistant depression
Prediction of lithium carbonate response in treatment-resistant depression using brain imaging
Prediction of lithium augmentation in treatment-resistant depression
Japan |
Treatment-resistant Depression
Psychiatry | Radiology |
Others
NO
We aim to investigate which abnormalities of SPECT would be predictors of lithium augmentation for treatment-resistant depression
Others
We aim to investigate predictors of effectiveness.
Exploratory
Pragmatic
After the augmentation therapy, the patients will be divided into responders (a 50% or greater decrease in HAM-D scores between before and after treatment) and non-responders (less than 50%). The predictors (the differences between responders and non-responders) will be analyzed using mental and physical assessments including brain imaging before the therapy.
Observational
20 | years-old | <= |
69 | years-old | >= |
Male and Female
This study should be conducted in voluntary inpatients who meet DSM-IV-TR criteria for major depression and are resistant to conventional antidepressant pharmacotherapy.
Treatment resistance is defined by history of failure to respond to antidepressants of more than two different classes, one of which should be TCA, after at least 4 weeks of therapy at an acceptable therapeutic dose.
Written informed consent should be obtained voluntarily from all participants after the purpose, the methods and means, the effects, and the inconveniences and hazards have been fully explained.
Patients should be free of an experience of lithium augmentation during this episode. Other exclusion criteria are: present or previous history of brain infarction; present history of severe unstable physical illness including thyroidal dysfunction and glaucoma; hypersensitivity of lithium; fertile and sexually active women not on contraceptives; present use of epinephrine; high risk of suicide.
30
1st name | |
Middle name | |
Last name | Nagahisa Okamoto |
National Center of Neurology and Psychiatry, Musashi Hospital
Department of Psychiatry
4-1-1, Ogawahigashi-machi, Kodaira City, Tokyo
042-341-2711
1st name | |
Middle name | |
Last name | Mayumi Sato |
National Center of Neurology and Psychiatry, Musashi Hospital
Department of Psychiatry
042-341-2711
National Center of Neurology and Psychiatry, Musashi Hospital
The Grant-in-Aid for Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare
Japan
NO
2008 | Year | 03 | Month | 01 | Day |
Partially published
Preinitiation
2007 | Year | 10 | Month | 26 | Day |
2008 | Year | 03 | Month | 01 | Day |
2011 | Year | 02 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
The predictors (the differences between responders and non-responders) will be analyzed using mental (Temperament and Character Inventory, Hamilton Rating Scale for Depression, Beck Depression Inventory II, Clinical Global Impression, Mini Mental State Examination
)and physical(SPECT, MRI, etc.)assessments .
2008 | Year | 02 | Month | 20 | Day |
2011 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001250